Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas B Stoker

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Movement Disorders : Official Journal of the Movement Disorder Society|October 30, 2020
Hydrocephalus Complicating Intrathecal Antisense Oligonucleotide Therapy for Huntington's DiseaseThomas B Stoker, Katie E R Andresen, Roger A Barker
Practical Neurology|August 20, 2021
Huntington's disease: diagnosis and managementThomas B Stoker, Sarah L Mason, Julia C Greenland, et al.
Journal of Neurology|July 27, 2022
DCTN1 mutation associated parkinsonism: case series of three new families with perry syndromeThomas B Stoker, Vaclav Dostal, Jeffrey Cochius, et al.
FEBS Letters|September 20, 2019
Dual modulation of neuron-specific microRNAs and the REST complex promotes functional maturation of human adult induced neuronsMarcella Birtele, Yogita Sharma, Srisaiyini Kidnapillai, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 4, 2020
A common polymorphism in <i>SNCA</i> is associated with accelerated motor decline in <i>GBA</i>-Parkinson's diseaseThomas B Stoker, Marta Camacho, Sophie Winder-Rhodes, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 19, 2020
Impact of <i>GBA1</i> variants on long-term clinical progression and mortality in incident Parkinson's diseaseThomas B Stoker, Marta Camacho, Sophie Winder-Rhodes, et al.
Communications Biology|May 12, 2026
Early α-synuclein-mediated mitochondrial dysfunction in a human cell model of Parkinson's disease dementiaMaha S Alfaidi, Léa M D Wenger, Kornélia Szebényi, et al.
Stem Cell Reports|September 23, 2022
Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson's diseaseJanelle Drouin-Ouellet, Emilie M Legault, Fredrik Nilsson, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Movement Disorders : Official Journal of the Movement Disorder Society|October 30, 2020
Hydrocephalus Complicating Intrathecal Antisense Oligonucleotide Therapy for Huntington's DiseaseThomas B Stoker, Katie E R Andresen, Roger A Barker
Practical Neurology|August 20, 2021
Huntington's disease: diagnosis and managementThomas B Stoker, Sarah L Mason, Julia C Greenland, et al.
Journal of Neurology|July 27, 2022
DCTN1 mutation associated parkinsonism: case series of three new families with perry syndromeThomas B Stoker, Vaclav Dostal, Jeffrey Cochius, et al.
FEBS Letters|September 20, 2019
Dual modulation of neuron-specific microRNAs and the REST complex promotes functional maturation of human adult induced neuronsMarcella Birtele, Yogita Sharma, Srisaiyini Kidnapillai, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 4, 2020
A common polymorphism in <i>SNCA</i> is associated with accelerated motor decline in <i>GBA</i>-Parkinson's diseaseThomas B Stoker, Marta Camacho, Sophie Winder-Rhodes, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 19, 2020
Impact of <i>GBA1</i> variants on long-term clinical progression and mortality in incident Parkinson's diseaseThomas B Stoker, Marta Camacho, Sophie Winder-Rhodes, et al.
Communications Biology|May 12, 2026
Early α-synuclein-mediated mitochondrial dysfunction in a human cell model of Parkinson's disease dementiaMaha S Alfaidi, Léa M D Wenger, Kornélia Szebényi, et al.
Stem Cell Reports|September 23, 2022
Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson's diseaseJanelle Drouin-Ouellet, Emilie M Legault, Fredrik Nilsson, et al.
Pageof 2